ROS1 Gene Mutation
Drug | Drug Name | Drug Description |
---|---|---|
DB14707 | Cemiplimab | A programmed death receptor-1 blocking antibody used to treat cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB14707 | Cemiplimab | Programmed cell death protein 1 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB12001 | Abemaciclib | 2 | Recruiting | 1 |
DB15568 | Adagrasib | 2 | Recruiting | 1 |
DB11595 | Atezolizumab | 2 | Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Recruiting | 1 |
DB12267 | Brigatinib | 2 | Withdrawn | 1 |
DB00958 | Carboplatin | 2 | Recruiting | 1 |
DB11986 | Entrectinib | 2 | Recruiting | 1 |
DB15186 | Paxalisib | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
DB00642 | Pemetrexed | 2 | Recruiting | 1 |
DB14797 | SEphB4-HSA | 2 | Active Not Recruiting | 1 |